SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No 2)
CARDIOVASCULAR SYSTEMS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
141619106
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2009
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|X| Rule 13d-1(b)
|_| Rule 13d-1(c)
|_| Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
----------------------------- ---------------------------
CUSIP No. 141619106 SCHEDULE 13G/A Page 2 of 10 Pages
----------------------------- ---------------------------
--------------------------------------------------------------------------------
1 Names of Reporting Persons
Maverick Capital, Ltd. - 75-2482446
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Texas
--------------------------------------------------------------------------------
| 5 | Sole Voting Power
| | 2,183,152 (1)
Number of ---------------------------------------------------------------
Shares | 6 | Shared Voting Power
Beneficially | | 0
Owned by ----------------------------------------------------------------
Each | 7 | Sole Dispositive Power
Reporting | | 2,183,152 (1)
Person With ----------------------------------------------------------------
| 8 | Shared Dispositive Power
| | 0
--------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
2,183,152 (1)
--------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
|_|
--------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row 9
14.1%
--------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
IA
--------------------------------------------------------------------------------
___________________________
(1) Includes currently exercisable warrants to purchase 816,335 shares of
Common Stock, $0.001 par value.
----------------------------- ---------------------------
CUSIP No. 141619106 SCHEDULE 13G/A Page 3 of 10 Pages
----------------------------- ---------------------------
--------------------------------------------------------------------------------
1 Names of Reporting Persons
Maverick Capital Management, LLC - 75-2686461
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Texas
--------------------------------------------------------------------------------
| 5 | Sole Voting Power
| | 2,183,152 (1)
Number of ---------------------------------------------------------------
Shares | 6 | Shared Voting Power
Beneficially | | 0
Owned by ----------------------------------------------------------------
Each | 7 | Sole Dispositive Power
Reporting | | 2,183,152 (1)
Person With ----------------------------------------------------------------
| 8 | Shared Dispositive Power
| | 0
--------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
2,183,152 (1)
--------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
|_|
--------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row 9
14.1%
--------------------------------------------------------------------------------
12 Type of Reporting Person*
HC
--------------------------------------------------------------------------------
___________________________
(1) Includes currently exercisable warrants to purchase 816,335 shares of
Common Stock, $0.001 par value.
----------------------------- ---------------------------
CUSIP No. 141619106 SCHEDULE 13G/A Page 4 of 10 Pages
----------------------------- ---------------------------
--------------------------------------------------------------------------------
1 Names of Reporting Persons
Lee S. Ainslie III
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
| 5 | Sole Voting Power
| | 2,183,152 (1)
Number of ---------------------------------------------------------------
Shares | 6 | Shared Voting Power
Beneficially | | 0
Owned by ----------------------------------------------------------------
Each | 7 | Sole Dispositive Power
Reporting | | 2,183,152 (1)
Person With ----------------------------------------------------------------
| 8 | Shared Dispositive Power
| | 0
--------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
2,183,152 (1)
--------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
|_|
--------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row 9
14.1%
--------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
HC
--------------------------------------------------------------------------------
___________________________
(1) Includes currently exercisable warrants to purchase 816,335 shares of
Common Stock, $0.001 par value.
Item 1(a) Name of Issuer:
Cardiovascular Systems, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
651 Campus Drive
St. Paul, Minnesota 55112-3495
Item 2(a) Name of Person Filing:
This Schedule 13G (the "Schedule 13G") is being filed on behalf of
each of the following persons (each, a "Reporting Person"):
(i) Maverick Capital, Ltd.;
(ii) Maverick Capital Management, LLC; and
(iii) Lee S. Ainslie III ("Mr. Ainslie").
The Schedule 13G relates to Shares (as defined herein) held
for the accounts of Maverick Capital, Ltd.'s clients.
Item 2(b) Address of Principal Business Office, or, if none, Residence:
The address of the principal business office of (i) Maverick
Capital, Ltd. and Maverick Capital Management, LLC is 300 Crescent
Court, 18th Floor, Dallas, Texas 75201, and (ii) Mr. Ainslie is
767 Fifth Avenue, 11th Floor, New York, New York 10153.
Item 2(c) Citizenship:
(i) Maverick Capital, Ltd. is a Texas limited partnership;
(ii) Maverick Capital Management, LLC is a Texas limited
liability company; and
(iii) Mr. Ainslie is a citizen of the United States.
Item 2(d) Title of Class of Securities:
Common Stock, $0.001 par value (the "Shares").
Item 2(e) CUSIP Number:
141619106
Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) |_| Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o).
Page 5 of 10 Pages
(b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) |_| Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) |_| Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) |X| An investment advisor in accordance with
ss.240.13d-1(b)(1)(ii)(E).
(f) |_| An employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F).
(g) |X| A parent holding company or control person in accordance with
ss.240.13d-1(b)(1)(ii)(G).
(h) |_| A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813).
(i) |_| A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3).
(j) |_| A non-U.S. institution in accordance with ss.
240.13d-1(b)(1)(ii)(J).
(k) |_| Group, in accordance with ss.240.13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in accordance with
ss.240.13d-1(b)(1)(ii)(J), please specify the type of institution:______________
Item 4 Ownership
Ownership as of December 31, 2009 is incorporated by reference to
items (5) - (9) and (11) of the cover page of the Reporting
Person.
Maverick Capital, Ltd. is an investment adviser registered under
Section 203 of the Investment Advisers Act of 1940 and, as such,
may be deemed to have beneficial ownership of the Shares which are
the subject of this filing through the investment discretion it
exercises over its clients' accounts. Maverick Capital Management,
LLC is the General Partner of Maverick Capital, Ltd. Mr. Ainslie
is the manager of Maverick Capital Management, LLC and is granted
sole investment discretion pursuant to Maverick Capital
Management, LLC's Regulations.
Item 5 Ownership of Five Percent or Less of a Class
Not applicable.
Item 6 Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company or
Control Person
Page 6 of 10 Pages
Not applicable.
Item8 Identification and Classification of Members of the Group
Not applicable.
Item9 Notice of Dissolution of Group
Not applicable.
Item10 Certifications
By signing below each of the Reporting Persons certifies that, to
the best of such person's knowledge and belief, the securities
referred to above were acquired and are held in the ordinary
course of business and were not acquired and are not held for the
purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any
transaction having that purpose or effect.
Page 7 of 10 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 16, 2010 MAVERICK CAPITAL, LTD.
By: Maverick Capital Management, LLC,
Its General Partner
By: Lee S. Ainslie III, Manager
By: /s/ John T. McCafferty
----------------------
John T. McCafferty
Under Power of Attorney
dated February 13, 2003
Date: February 16, 2010 MAVERICK CAPITAL MANAGEMENT, LLC
By: Lee S. Ainslie III, Manager
By: /s/ John T. McCafferty
----------------------
John T. McCafferty
Under Power of Attorney
dated February 13, 2003
Date: February 16, 2010 LEE S. AINSLIE III
By: /s/ John T. McCafferty
----------------------
John T. McCafferty
Under Power of Attorney
dated February 13, 2003
Page 8 of 10 Pages
EXHIBIT INDEX
A. Joint Filing Agreement, dated March 10, 2009, by and among Maverick
Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III.
Page 9 of 10 Pages
Exhibit A
Joint Filing Agreement
The undersigned hereby agree that the statement on Schedule 13G with
respect to the Common Stock, $0.001 par value of Cardiovascular Systems, Inc.,
dated as of March 10, 2009, is, and any amendments thereto (including amendments
on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of
each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)
under the Securities Exchange Act of 1934.
Date: March 10, 2009
MAVERICK CAPITAL, LTD.
By: Maverick Capital Management, LLC
Its General Partner
By: Lee S. Ainslie III, Manager
By: /s/ John T. McCafferty
---------------------------------
John T. McCafferty
Under Power of Attorney dated
February 13, 2003
MAVERICK CAPITAL MANAGEMENT, LLC
By: Lee S. Ainslie III, Manager
By: /s/ John T. McCafferty
------------------------------------
John T. McCafferty
Under Power of Attorney dated
February 13, 2003
LEE S. AINSLIE III
By: /s/ John T. McCafferty
------------------------------------------
John T. McCafferty
Under Power of Attorney dated
February 13, 2003
Page 10 of 10 Pages